Skip to content

Member

Michalis HADJIPANTELA

EPP · Cyprus

Group
EPP PPE
Country
Cyprus
Roll-call participation
89.5 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
92.3 %ⓘ of 555 votes where the group had a line · EPP median 95.6 %
More facts (5)
National party
DI.SY. Democratic Rally
In office
Since 16 Jul 2024
Against clear line
21 of 514 votesⓘ
Committees
BUDG (substitute), ECON, ENVI (substitute), ITRE (substitute), SANT
Member id
256985
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

89.5 %

555 of 620 final votes while in office

EPP median: 90.6 % (−1.0 pts)

Chamber median: 90.6 %

With majority line ⓘ

92.3 %

512 of 555 votes where their group had a line

EPP median: 95.6 % (−3.3 pts)

Against clear line ⓘ

4.1 %

21 of 514 votes where their group had a clear line

9 opposite (for ↔ against), 12 abstained against the line

Abstention ⓘ

2.7 %

15 of 555 votes cast

Participation 89.5 % — EPP median 90.6 %, 192 members.ⓘ
Data as a table
Participation among the 192 members of the EPP with enough votes.
FigureParticipation
Michalis HADJIPANTELA89.5 %
EPP median90.6 %
Lowest in the group18.4 %
Highest in the group99.8 %
Members192
With majority line 92.3 % — EPP median 95.6 %, 192 members.ⓘ
Data as a table
With majority line among the 192 members of the EPP with enough votes.
FigureWith majority line
Michalis HADJIPANTELA92.3 %
EPP median95.6 %
Lowest in the group67.8 %
Highest in the group99.0 %
Members192
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: Abstained Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 10 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Loucas FOURLAS EPPCyprus97 % of 3 767 shared89 %
Eleonora MELETI EPPGreece94 % of 4 113 shared89 %
Emmanouil KEFALOGIANNIS EPPGreece93 % of 4 578 shared89 %
Dimitris TSIODRAS EPPGreece93 % of 4 780 shared89 %
Georgios AFTIAS EPPGreece93 % of 4 385 shared89 %
Vangelis MEIMARAKIS EPPGreece93 % of 4 308 shared89 %
Fredis BELERIS EPPGreece93 % of 4 255 shared89 %
Elissavet VOZEMBERG-VRIONIDI EPPGreece92 % of 3 434 shared89 %
Manfred WEBER EPPGermany92 % of 4 293 shared89 %
Siegfried MUREŞAN EPPRomania92 % of 5 005 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Urmas PAET RenewEstonia84 % of 4 683 shared82 %
Dan BARNA RenewRomania83 % of 4 509 shared82 %
Hilde VAUTMANS RenewBelgium82 % of 5 005 shared82 %
Sophie WILMÈS RenewBelgium82 % of 3 639 shared82 %
Bart GROOTHUIS RenewNetherlands82 % of 3 838 shared82 %
Eugen TOMAC RenewRomania82 % of 3 813 shared82 %
Katri KULMUNI RenewFinland82 % of 3 990 shared82 %
Elsi KATAINEN RenewFinland82 % of 5 149 shared82 %
Dan NICA S&DRomania82 % of 3 285 shared75 %
Benoit CASSART RenewBelgium82 % of 4 696 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on BudgetsBUDG CommitteeSubstitute19 Jul 2024now
Committee on Economic and Monetary AffairsECON CommitteeMember19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Industry, Research and EnergyITRE CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Subcommittee on Tax MattersFISC SubcommitteeMember19 Jul 2024now
Delegation for relations with the People's Republic of ChinaD-CN DelegationSubstitute19 Sept 2024now
Delegation for relations with IranD-IR DelegationMember19 Sept 2024now
Delegation for relations with the United StatesD-US DelegationSubstitute19 Sept 2024now
Intergroup on Attracting Investment to Ensure a Competitive and Sustainable European UnionIG10-03 Intergroup / working groupMember31 Jan 2025now

Show all 18 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
No dossier namedOfficial delegationECON14 Sept 2026
No dossier namedShadow rapporteur for an opinionENVI1 Jul 2026
No dossier namedOfficial delegationSANT29 Jun 2026
No dossier namedOfficial delegationECON29 Jun 2026
No dossier namedOpinion rapporteurSANT22 Jun 2026
No dossier namedOpinion rapporteurENVI17 Jun 2026
91st EU-US INTER-PARLIAMENTARY MEETING OF THE TRANSLANTIC LEGISLATORS DIALOGUE 19-20 JUNE CYPRUSOfficial delegationD-US15 Jun 2026
Mobilisation of the European Union Solidarity Fund: assistance to Romania regarding the floods at the end of May 2025, Cyprus following the wildfires in July 2025 and Spain following the wildfires in August 2025Shadow rapporteurBUDG3 Jun 2026
No dossier namedOfficial delegationBUDG13 May 2026
No dossier namedOfficial delegationENVI11 Mar 2026

Show all 49 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

37 contributions recorded; 3 on behalf of their group; 55 minutes of speaking time.

Show all 37 recent contributions

Questions and motions, 48

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
7 Sept 2026Polisario Front E-10-2026-003521Written questionwith 9 co-authorsNot yet answered
16 Jul 2026Ensuring the continued operation of the Blue Flag Programme under Directive (EU) 2024/825 E-10-2026-003031Written questionwith 29 co-authors18 Sept 2026
30 Jun 2026Implementation of new pharmaceutical legislation E-10-2026-002706Written question3 Sept 2026
4 Jun 2026Economic support for the tourism sector in Cyprus P-10-2026-002313Priority written question8 Jul 2026
7 Apr 2026Illegal quarrying in the occupied areas of Cyprus E-10-2026-001399Written question22 May 2026
7 Apr 2026Non-recognition of degree from institution recognised by the European Higher Education Area E-10-2026-001400Written question10 Jun 2026
18 Mar 2026Foot-and-mouth disease and issues regarding practical implementation of the legislation E-10-2026-001111Written question8 May 2026
25 Feb 2026Foot-and-mouth disease outbreak in Cyprus P-10-2026-000777Priority written question23 Apr 2026
8 Dec 2025Ban on the sale of nitrous oxide to the general public O-10-2025-000046Oral questionwith 42 co-authorsNot yet answered
19 Nov 2025Potential inclusion of Pernambuco in Convention on International Trade in Endangered Species of Wild Fauna and Flora Appendix I and safeguarding European cultural heritage E-10-2025-004606Written questionwith 13 co-authors21 Jan 2026

Show all 48 questions and motions

Amendments tabled in committee, 112

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT2
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT2
15 Jul 2026General budget of the European Union for the financial year 2027 - all sections SANT-AM-789117 SANT1
15 Jul 2026Amending Regulation (EU) 2023/1542 and Regulation (EU) 2024/1244 as regards simplification of some requirements and reduction of administrative burden ENVI-AM-790846 ENVI1
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ532
13 Jul 2026Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790958 AGRI1
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ536
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ532
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ531

Show all 112 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Cyprus National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Michalis HADJIPANTELA”. Member record. memberId 256985. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256985?page=4&scope=final&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256985. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256985?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-256985,
  author = {{EU Parl Watch Research}},
  title = {{Michalis HADJIPANTELA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256985?page=4&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/256985?page=4&scope=final&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256985. Official source: https://www.europarl.europa.eu/meps/en/256985. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}